- United States
- /
- Medical Equipment
- /
- NYSE:SYK
Is Now An Opportune Moment To Examine Stryker Corporation (NYSE:SYK)?
Let's talk about the popular Stryker Corporation (NYSE:SYK). The company's shares received a lot of attention from a substantial price movement on the NYSE over the last few months, increasing to US$300 at one point, and dropping to the lows of US$254. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Stryker's current trading price of US$271 reflective of the actual value of the large-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at Stryker’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.
View our latest analysis for Stryker
What Is Stryker Worth?
According to my valuation model, Stryker seems to be fairly priced at around 10.26% above my intrinsic value, which means if you buy Stryker today, you’d be paying a relatively fair price for it. And if you believe that the stock is really worth $245.63, there’s only an insignificant downside when the price falls to its real value. What's more, Stryker’s share price may be more stable over time (relative to the market), as indicated by its low beta.
Can we expect growth from Stryker?
Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. Stryker's earnings over the next few years are expected to increase by 59%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value.
What This Means For You
Are you a shareholder? SYK’s optimistic future growth appears to have been factored into the current share price, with shares trading around its fair value. However, there are also other important factors which we haven’t considered today, such as the financial strength of the company. Have these factors changed since the last time you looked at the stock? Will you have enough confidence to invest in the company should the price drop below its fair value?
Are you a potential investor? If you’ve been keeping an eye on SYK, now may not be the most advantageous time to buy, given it is trading around its fair value. However, the positive outlook is encouraging for the company, which means it’s worth diving deeper into other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.
If you want to dive deeper into Stryker, you'd also look into what risks it is currently facing. You'd be interested to know, that we found 2 warning signs for Stryker and you'll want to know about them.
If you are no longer interested in Stryker, you can use our free platform to see our list of over 50 other stocks with a high growth potential.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NYSE:SYK
Solid track record average dividend payer.